Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare Services Industry Analysis

UpdatedOct 25, 2025
DataAggregated Company Financials
Companies156
  • 7D1.1%
  • 3M19.9%
  • 1Y-14.4%
  • YTD-4.2%

In the last week, the Healthcare Services industry is up 1.1%, with UnitedHealth Group leading the way, up 1.7%. However, the industry is down 14% over the past year. Earnings are forecast to grow by 13% annually.

Industry Valuation and Performance

Has the U.S. Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 26 Oct 2025US$935.6bUS$2.1tUS$49.3b21.6x19x0.4x
Tue, 23 Sep 2025US$879.3bUS$2.1tUS$49.3b21.5x17.8x0.4x
Thu, 21 Aug 2025US$847.3bUS$2.1tUS$49.3b21.4x17.2x0.4x
Sat, 19 Jul 2025US$806.4bUS$2.1tUS$52.2b20.8x15.5x0.4x
Mon, 16 Jun 2025US$884.3bUS$2.1tUS$52.7b20.5x16.8x0.4x
Wed, 14 May 2025US$948.4bUS$2.1tUS$52.4b21.1x18.1x0.5x
Fri, 11 Apr 2025US$1.1tUS$1.7tUS$41.8b22.9x26.1x0.6x
Sun, 09 Mar 2025US$1.0tUS$1.7tUS$41.4b24.9x24.3x0.6x
Tue, 04 Feb 2025US$1.1tUS$2.0tUS$42.5b23.7x25.9x0.6x
Thu, 02 Jan 2025US$1.0tUS$2.0tUS$42.3b22x23.7x0.5x
Sat, 30 Nov 2024US$1.2tUS$2.0tUS$41.4b24.4x28.3x0.6x
Mon, 28 Oct 2024US$1.1tUS$1.9tUS$43.7b23.9x25.8x0.6x
Wed, 25 Sep 2024US$1.2tUS$1.9tUS$43.3b25.5x27.6x0.6x
Fri, 23 Aug 2024US$1.2tUS$1.9tUS$43.3b26.1x27.8x0.6x
Sun, 21 Jul 2024US$1.2tUS$1.9tUS$42.6b26.2x27.1x0.6x
Tue, 18 Jun 2024US$1.1tUS$1.9tUS$43.4b25.8x25.2x0.6x
Thu, 16 May 2024US$1.1tUS$1.9tUS$43.5b26.9x25.6x0.6x
Sat, 13 Apr 2024US$1.1tUS$1.8tUS$49.8b25x21.2x0.6x
Mon, 11 Mar 2024US$1.1tUS$1.8tUS$51.0b24.2x21.6x0.6x
Wed, 07 Feb 2024US$1.1tUS$1.8tUS$50.1b22.4x22.4x0.6x
Fri, 05 Jan 2024US$1.2tUS$1.8tUS$50.1b23.9x23.6x0.7x
Sun, 03 Dec 2023US$1.2tUS$1.8tUS$51.1b23x22.6x0.6x
Tue, 31 Oct 2023US$1.1tUS$1.8tUS$46.8b21.8x24.1x0.6x
Thu, 28 Sep 2023US$1.1tUS$1.8tUS$46.9b22.1x23.6x0.6x
Sat, 26 Aug 2023US$1.1tUS$1.8tUS$46.7b21.9x23.4x0.6x
Mon, 24 Jul 2023US$1.1tUS$1.7tUS$46.7b24x24.6x0.7x
Wed, 21 Jun 2023US$1.1tUS$1.7tUS$45.7b22.7x23.5x0.6x
Fri, 19 May 2023US$1.1tUS$1.7tUS$45.7b22x23.8x0.6x
Sun, 16 Apr 2023US$1.1tUS$1.4tUS$44.2b23.1x25x0.8x
Tue, 14 Mar 2023US$1.0tUS$1.4tUS$44.2b21.3x23.4x0.7x
Thu, 09 Feb 2023US$1.1tUS$1.4tUS$43.5b22x25.6x0.8x
Sat, 07 Jan 2023US$1.1tUS$1.4tUS$44.4b21x25.3x0.8x
Mon, 05 Dec 2022US$1.2tUS$1.4tUS$44.4b20.8x27.5x0.9x
Wed, 02 Nov 2022US$1.2tUS$1.4tUS$46.5b19.9x26.6x0.9x
Price to Earnings Ratio

26.6x


Total Market Cap: US$1.2tTotal Earnings: US$46.5bTotal Revenue: US$1.4tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Services Industry Price to Earnings3Y Average 23.5x202320242025
Current Industry PE
  • Investors are pessimistic on the American Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 19.0x which is lower than its 3-year average PE of 23.5x.
  • The industry is trading close to its 3-year average PS ratio of 0.61x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 2.0% per year over the last three years.
  • Revenues for these companies have grown 15% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare industry?

US Market1.96%
Healthcare1.89%
Healthcare Services1.10%
Healthcare Facilities3.54%
Healthcare Distributors2.36%
Managed Healthcare1.01%
Healthcare Services0.39%
Industry PE
  • Investors are most optimistic about the Healthcare Distributors industry even though it's trading below its 3-year average PE ratio of 38.2x.
    • Analysts are expecting annual earnings growth of 13.7%, which is higher than its past year's earnings growth of 6.3% per year.
  • Investors are most pessimistic about the Managed Healthcare industry, which is trading below its 3-year average of 22.1x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 20% over the next 5 years.
  • This is better than its past earnings growth rate of 7.4% per year.
  • In contrast, the Managed Healthcare industry is expected to see its earnings grow by 8.0% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
UNH UnitedHealth GroupUS$362.501.7%
+US$5.3b		-35.8%PE15.4x
HCA HCA HealthcareUS$447.044.9%
+US$4.9b		23.0%PE16.5x
MCK McKessonUS$801.672.0%
+US$1.9b		58.0%PE31.5x
HUM HumanaUS$290.655.7%
+US$1.9b		11.5%PE22.2x
COR CencoraUS$332.712.5%
+US$1.6b		41.9%PE34x

Latest News

HCA
US$447.04
HCA Healthcare
7D
4.9%
1Y
23.0%
CVS
US$81.93
CVS Health
7D
-0.7%
1Y
45.0%

Managed Care Margin Recovery And Healthcare Benefits Will Shape Industry Prospects

Analysts have raised their fair value estimate for CVS Health to $86.20. This modest increase is supported by greater earnings visibility and expectations for margin recovery in the managed care sector.
MOH
US$163.32
Molina Healthcare
7D
-15.2%
1Y
-49.8%
BTSG
US$33.53
BrightSpring Health Services
7D
12.8%
1Y
116.3%
ELV
US$342.35
Elevance Health
7D
-1.8%
1Y
-19.5%
LH
US$279.49
Labcorp Holdings
7D
-2.3%
1Y
22.2%
UNH
US$362.50
UnitedHealth Group
7D
1.7%
1Y
-35.8%

Analyst Views Mixed as UnitedHealth Group Price Target Rises Amid Improved Outlook and Ongoing Challenges

UnitedHealth Group's analyst price target has been increased by $8.63 to $360.84. This reflects greater confidence among analysts following improved Medicare Advantage star ratings and enhanced earnings visibility.
CNC
US$34.07
Centene
7D
-3.4%
1Y
-46.9%

Analysts Lift Centene Price Target on Margin Recovery but Warn of Lasting Sector Headwinds

Centene's analyst fair value target has been increased from $34.63 to $36.00. Analysts highlight improving margin visibility and constructive EPS guidance updates as key factors supporting the upward revision.
HIMS
US$48.78
Hims & Hers Health
7D
-2.0%
1Y
124.5%
MCK
US$801.67
McKesson
7D
2.0%
1Y
58.0%

Analysts Boost McKesson Outlook Amid Strong Growth Guidance and Recent Valuation Adjustments

Analysts have raised their average fair value estimate for McKesson to $836.71 from $829.57. This change is attributed to increased long-term growth guidance and improved business visibility following the company’s recent investor day.
AVAH
US$9.43
Aveanna Healthcare Holdings
7D
-4.4%
1Y
88.2%
DGX
US$182.18
Quest Diagnostics
7D
-3.9%
1Y
17.5%
COR
US$332.71
Cencora
7D
2.5%
1Y
41.9%
HUM
US$290.65
Humana
7D
5.7%
1Y
11.5%

AI, In-Home Visits, Medicaid And CenterWell Will Improve Care Delivery

Humana’s analyst price target increased slightly to $294.54 from $292.87. Analysts cite improved earnings visibility and the stability of Medicare Advantage star ratings as supporting factors for the upward revision.
THC
US$210.38
Tenet Healthcare
7D
5.2%
1Y
50.5%

Demographic Trends And Technology Efficiency Will Transform Healthcare Delivery

Tenet Healthcare's analyst price targets have moved higher, with the average fair value estimate increasing by approximately $5 to $204.90 per share. Analysts cited favorable state-directed payment approvals, strong quarterly results, and a solid earnings outlook for the hospital group.
CAH
US$161.89
Cardinal Health
7D
3.5%
1Y
46.0%